Why are autologous Adult stem cell treatments being Outsourced?

August 3, 2012 ~ Pharmer

Patients from the U.S. have to go to other countries for autologous stem cell treatments (using the patient’s own cells) because of FDA regulations.

No, it’s not because of any restrictions by President Bush, (which limited funding for embryonic stem cells, not adult stem cells).

The FDA considers the use of the patients’ own cells as a new drug, because they go through processing for the purpose of increasing their numbers. Use of such cells would require a new drug application to the FDA, therefore the procedures have to be done in other countries.

A court has recently ruled, against the interest of Regenerative Sciences, a clinic that treats orthopedic patients, that the FDA retains the authority to regulate stem cell treatments.

Yes, it is the FDA, not President Bush, which is causing the outsourcing of autologous stem cell treatments.

The Homies Want A Bigger Piece of Bono’s Pie

June 6, 2011 ~ Pharmer

‘Saint Bono’ facing huge Glastonbury protest ¿ for avoiding tax | Mail Online.

Art Uncut, an Irish activist group, is whining at Bono, of the richest Rockers- U2, because he has outsourced the publishing part of his industry outside of Ireland, ostensibly for the purpose of minimizing taxes.

Bono’s a leftie of course, and has made a name for himself by espousing charitable causes in the third world. There will be a protest at the Glastonbury festival demanding that Bono “Pay UP” as the poor of Ireland are suffering.

U2 has also been criticized in the past, by politicians, for moving parts of their business to the Netherlands, while at the same time urging their own government to do more for the poor.

FDA Can’t Handle Drug Shortages, and in Some Cases, is Causing them

February 19, 2011 ~ Pharmer ~ 3 Comments

Drug Shortages: A Deadly Problem With No Cure in Sight – DailyFinance.

Pharmer’s going to be featuring some articles describing what is seen in the hospitals in the past couple of years……….. ever worsening shortages of chemotherapeutic and injectable drugs. This has become a severe public health problem due to inability to treat some cancers, and unnecessary deaths due to unavailable treatments or errors involving drugs used as substitutes.

Here is the American Society of Hospital Pharmacists drug shortage management resource center.

Pharmer thinks this problem has several underlying causes : supply and demand, need to import raw materials, economic pressures, taxes, outsourcing, government incompetence, an increasingly useless FDA, natural selection, and death panel philosophy.

The last factor curbs government enthusiasm for addressing the drug shortage problem vigorously. Increased deaths lighten the load on social security, medicare and medicaid, and therefore the shortages become a means of obamacare cost control.